Optimal follow‐up with somatostatin receptor PET / CT imaging in patients with small intestinal neuroendocrine tumours

Documenti analoghi

• Quality of life as a predictor for survival in patients with small intestinal neuroendocrine tumours
  di: Håkan Ohlsson, et al.
  Pubblicazione: (2025)
• Prevalence of metastases outside the liver and abdominal lymph nodes on 68 Ga‐DOTATOC‐PET / CT in patients with small intestinal and pancreatic neuroendocrine tumours
  di: Maria Wedin, et al.
  Pubblicazione: (2024)
• Impact on symptoms and survival of bone metastases in patients with small‐intestinal neuroendocrine tumours
  di: Maria Wedin, et al.
  Pubblicazione: (2025)
• Telotristat ethyl affects tumour‐fibroblast crosstalk in small intestinal neuroendocrine tumours
  di: Harry Hodgetts, et al.
  Pubblicazione: (2025)
• Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors
  di: Giulia Santo, et al.
  Pubblicazione: (2025)